| Authors: |
Camidge DR; University of Colorado Cancer Center, Aurora, CO., Kim HR; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Ahn MJ; Samsung Medical Center, Seoul, South Korea., Yang JCH; National Taiwan University Hospital, Taipei, Taiwan., Han JY; National Cancer Center, Goyang, South Korea., Hochmair MJ; Department of Respiratory and Critical Care Medicine, Krankenhaus Nord-Klinik Floridsdorf, Vienna, Austria., Lee KH; Chungbuk National University Hospital, Cheongju, South Korea., Delmonte A; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, Italy., García Campelo MR; Complejo Hospitalario Universitario A Coruna, Coruna, Spain., Kim DW; Seoul National University Hospital, Seoul, South Korea., Griesinger F; Pius-Hospital Oldenburg, University of Oldenburg, Oldenburg, Germany., Felip E; Vall d'Hebron University Hospital, Barcelona, Spain., Califano R; The Christie NHS Foundation Trust and Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom., Spira A; Virginia Cancer Specialists and US Oncology Research, The Woodlands, TX., Gettinger SN; Yale Cancer Center, New Haven, CT., Tiseo M; University Hospital of Parma, Parma, Italy., Lin HM; Millennium Pharmaceuticals, Cambridge, MA., Gupta N; Millennium Pharmaceuticals, Cambridge, MA., Hanley MJ; Millennium Pharmaceuticals, Cambridge, MA., Ni Q; Millennium Pharmaceuticals, Cambridge, MA., Zhang P; Millennium Pharmaceuticals, Cambridge, MA., Popat S; Royal Marsden Hospital, London, United Kingdom.; The Institute of Cancer Research, London, United Kingdom. |